American Assets Capital Advisers, LLC
Annual return '25
+83.2%
SPY '25
+17.7%
Alpha
+65.5ptsvs SPY
Invested
$1.8B
Holdings
32
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 93%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$APGE
APOGEE THERAPEUTICS INC
Held since at least Q1 2024
21.4%
02
$OCUL
OCULAR THERAPEUTIX INC
Held since at least Q1 2024
9.7%
03
$CDTX
CIDARA THERAPEUTICS INC
Held since at least Q1 2024
5.7%
04
$VRDN
VIRIDIAN THERAPEUTICS INC
Held since at least Q1 2024
5.3%
05
$KALV
KALVISTA PHARMACEUTICALS INC
Held since at least Q1 2024
5.2%
06
$ORKA
ORUKA THERAPEUTICS INC
Held since at least Q1 2024
5.0%
07
$ORIC
ORIC PHARMACEUTICALS INC
Held since at least Q1 2024
5.0%
08
$ELVN
ENLIVEN THERAPEUTICS INC
Held since at least Q1 2024
4.2%
09
$COGT
COGENT BIOSCIENCES INC
Held since at least Q1 2024
3.6%
10
$CTMX
CYTOMX THERAPEUTICS INC
Held since at least Q1 2024
3.1%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 08:09 UTC.